Comment on CMS-2026-1255-0001
The AIDS InstituteSupportAdvocacy
Summary: The AIDS Institute supports the proposed rule to improve interoperability and streamline prior authorization for drugs, noting it will improve patient access and reduce provider burden. They advocate for specific improvements, including shorter decision timelines, more detailed denial justifications, and protections against the use of Alternative Funding Programs to delay care.
The AIDS Institute believes with some additions and clarifications, this rule moves the healthcare industry in the right direction to improve patient access, reduce provider burden, and decrease system inefficiencies. We submit the attached comments with specific considerations for CMS. Please see attached file(s)